Furthermore, considering the confidence interval was 1.00, the result did not reach statistical significance, which indicates that although there is a slight association between SGLT2 inhibitors and the cancer risk of T2DM patients, the evidence does not support a causal relationship.
← all excerpts
Safety evaluation of Sodium-glucose cotransporter 2 inhibitors for cancer risk in specific populations: systematic review and meta-analysis.
1
—
—